Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: Implications for in vitro maturation

Stem Cells

Volumn 33, Issue 5, 2015, Pages 1456-1469

  Zhang, Miao ^a,b   Schulte, Jan Sebastian ^a   Heinick, Alexander ^a   Piccini, Ilaria ^c,d   Rao, Jyoti ^a,b   Quaranta, Roberto ^a,b   Zeuschner, Dagmar ^e   Malan, Daniela ^f   Kim, Kee Pyo ^g   Röpke, Albrecht ^h   Sasse, Philipp ^g   Araúzo Bravo, Marcos ^h,i,j   Seebohm, Guiscard ^d   Schöler, Hans ^g   Fabritz, Larissa ^c,k   Kirchhof, Paulus ^c,k   Müller, Frank Ulrich ^a   Greber, Boris ^a,b  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^b Department of Cell and Developmental Biology ^*  (Germany)

^c CHEMICAL GENOMICS CENTRE OF THE MAX PLANCK SOCIETY   (Germany)

^d Institute for Pharmacology and Toxicology   (Germany)

^e INST OF REPRO MED OF THE UNIV   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g UNIVERSITY OF BONN   (Germany)

^h UNIVERSITY OF MÜNSTER   (Germany)

ⁱ BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^j BASQUE FOUNDATION FOR SCIENCE   (Spain)

^k UNIVERSITY OF BIRMINGHAM   (United Kingdom)

more..

Author keywords

cardiac differentiation; human pluripotent stem cells; in vitro maturation

Indexed keywords

SERUM ALBUMIN;

ARTICLE; CARDIAC INDUCTION; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PHYSIOLOGICAL PROCESS; PLURIPOTENT STEM CELL; PROCESS OPTIMIZATION; SIGNAL TRANSDUCTION; CARDIAC MUSCLE CELL; CYTOLOGY; HEART; MESODERM; PHYSIOLOGY;

CELL DIFFERENTIATION; HEART; HUMANS; MESODERM; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS;

EID: 84928549948     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1964     Document Type: Article

References (41)

1. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003; 107: 2733-2740.
2. Xu XQ, Graichen R, Soo SY, et al. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 2008; 76: 958-970.
3. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25: 1015-1024.
4. Zhang J, Klos M, Wilson GF, et al. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: The matrix sandwich method. Circ Res 2012; 111: 1125-1136.
5. Yang L, Soonpaa MH, Adler ED, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008; 453: 524-528.
6. Burridge PW, Thompson S, Millrod MA, et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011; 6: e18293.
7. Ren Y, Lee MY, Schliffke S, et al. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. J Mol Cell Cardiol 2011; 51: 280-287.
8. Tran TH, Wang X, Browne C, et al. Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem Cells 2009; 27: 1869-1878.
9. Yamauchi K, Sumi T, Minami I, et al. Cardiomyocytes develop from anterior primitive streak cells induced by beta-catenin activation and the blockage of BMP signaling in hESCs. Genes Cells 2010; 15: 1216-1227.
10. Lian X, Hsiao C, Wilson G, et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 2012; 109: E1848-1857.
11. Ueno S, Weidinger G, Osugi T, et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA 2007; 104: 9685-9690.
12. Minami I, Yamada K, Otsuji TG, et al. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep 2012; 2: 1448-1460.
13. Lanier M, Schade D, Willems E, et al. Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: A structure-activity relationship study based on inhibitors for the Wnt response. J Med Chem 2012; 55: 697-708.
14. Kattman SJ, Witty AD, Gagliardi M, et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011; 8: 228-240.
15. Zhang M, Scholer HR, Greber B,. Rapid and efficient generation of neurons from human pluripotent stem cells in a multititre plate format. J Vis Exp 2013: e4335.
16. Burridge PW, Matsa E, Shukla P, et al. Chemically defined generation of human cardiomyocytes. Nat Methods 2014; 11: 855-860.
17. Gould TD, Pfeifer K,. Imprinting of mouse Kvlqt1 is developmentally regulated. Hum Mol Genet 1998; 7: 483-487.
18. Kim KP, Thurston A, Mummery C, et al. Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Res 2007; 17: 1731-1742.
19. Kempf H, Olmer R, Kropp C, et al. Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture. Stem Cell Reports 2014; 3: 1132-1146.
20. Kadari A, Mekala S, Wagner N, et al. Robust generation of cardiomyocytes from human iPS cells requires precise modulation of BMP and WNT signaling. Stem Cell Rev 2014, doi: 10.1007/s12015-014-9564-6.
21. Tohyama S, Hattori F, Sano M, et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 2013; 12: 127-137.
22. Sartiani L, Bettiol E, Stillitano F, et al. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: A molecular and electrophysiological approach. Stem Cells 2007; 25: 1136-1144.
23. Kim C, Majdi M, Xia P, et al. Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev 2010; 19: 783-795.
24. Snir M, Kehat I, Gepstein A, et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 2003; 285: H2355-2363.
25. Kamakura T, Makiyama T, Sasaki K, et al. Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J 2013; 77: 1307-1314.
26. Yang X, Pabon L, Murry CE,. Engineering adolescence: Maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 2014; 114: 511-523.
27. Liu J, Lieu DK, Siu CW, et al. Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. Am J Physiol Cell Physiol 2009; 297: C152-159.
28. Tulloch NL, Muskheli V, Razumova MV, et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 2011; 109: 47-59.
29. Nunes SS, Miklas JW, Liu J, et al. Biowire: A platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 2013; 10: 781-787.
30. Moretti A, Bellin M, Welling A, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010; 363: 1397-1409.
31. Seki S, Nagashima M, Yamada Y, et al. Fetal and postnatal development of Ca2+ transients and Ca2+ sparks in rat cardiomyocytes. Cardiovasc Res 2003; 58: 535-548.
32. Kong CW, Akar FG, Li RA,. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: Insights from experimental models. Thromb Haemost 2010; 104: 30-38.
33. Zhang M, D'Aniello C, Verkerk AO, et al. Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue. Proc Natl Acad Sci USA 2014; 111: E5383-E5392.
34. Yang X, Rodriguez M, Pabon L, et al. Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol 2014; 72: 296-304.
35. Greber B, Coulon P, Zhang M, et al. FGF signalling inhibits neural induction in human embryonic stem cells. EMBO J 2011; 30: 4874-4884.
36. Frank S, Zhang M, Scholer HR, et al. Small molecule-assisted, line-independent maintenance of human pluripotent stem cells in defined conditions. PLoS One 2012; 7: e41958.
37. Barch MJ, Knutsen T, Spurbeck JL (eds.) The Agt Cytogenetics Laboratory Manual. Lippincott Williams & Wilkins, 1997.
38. Kahr PC, Piccini I, Fabritz L, et al. Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue. PLoS One 2011; 6: e26389.
39. McLean CY, Bristor D, Hiller M, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010; 28: 495-501.
40. Schulte JS, Seidl MD, Nunes F, et al. CREB critically regulates action potential shape and duration in the adult mouse ventricle. Am J Physiol Heart Circ Physiol 2012; 302: H1998-2007.
41. Ma J, Guo L, Fiene SJ, et al. High purity human-induced pluripotent stem cell-derived cardiomyocytes: Electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol 2011; 301: H2006-2017.